24 Hrs
Source:
بوابة الشروق
AI boosts pharma cost savings
Dr. Mohamed Amin, a specialist in artificial intelligence and computational biology at the National Institutes of Health (NIH) in the United States, was awarded the "FY26" prize in recognition of his scientific contributions to drug design using artificial intelligence. He explained that AI plays a key role in designing and identifying effective compounds for treating diseases by simulating the movement of proteins and drugs within cells, which has significantly reduced costs and time, especially in the pharmaceutical industry. He also shared his long scientific journey that began from a challenging background, where he spent years working on the streets before earning a scholarship to continue his studies up to the Ph.D., expressing pride in his contribution to the advancement of the field.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)